Tam VH - Search Results

1

In vitro model to simulate multiple drugs with distinct elimination half-lives.

Hudson CS, Smith JE, Eales BM, Nikolaou M, Tam VH. Hudson CS, et al. Among authors: tam vh. Int J Antimicrob Agents. 2023 Oct;62(4):106924. doi: 10.1016/j.ijantimicag.2023.106924. Epub 2023 Jul 9. Int J Antimicrob Agents. 2023. PMID: 37433386

2

Growth of Acinetobacter baumannii impacted by iron chelation.

Eales BM, Bai B, Merlau PR, Tam VH. Eales BM, et al. Among authors: tam vh. Lett Appl Microbiol. 2023 Feb 16;76(2):ovad019. doi: 10.1093/lambio/ovad019. Lett Appl Microbiol. 2023. PMID: 36731874 Free PMC article.

3

A novel method to evaluate ceftazidime/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections.

Gatti M, Tam VH, Gaibani P, Cojutti PG, Viale P, Pea F. Gatti M, et al. Among authors: tam vh. Int J Antimicrob Agents. 2023 Apr;61(4):106760. doi: 10.1016/j.ijantimicag.2023.106760. Epub 2023 Feb 18. Int J Antimicrob Agents. 2023. PMID: 36804371 Free PMC article.

4

Modeling Heterogeneous Bacterial Populations Exposed to Antibiotics: The Logistic-Dynamics Case.

Bhagunde PR, Nikolaou M, Tam VH. Bhagunde PR, et al. Among authors: tam vh. AIChE J. 2015 Aug;61(8):2385-2393. doi: 10.1002/aic.14882. Epub 2015 May 19. AIChE J. 2015. PMID: 37206682 Free PMC article.

5

Comparison of cefiderocol in-vitro susceptibility testing modalities.

Teran NS, Vuong L, Phe K, Lasco TM, Miller WR, Tam VH. Teran NS, et al. Among authors: tam vh. J Glob Antimicrob Resist. 2024 Mar 27;37:100-101. doi: 10.1016/j.jgar.2024.03.011. Online ahead of print. J Glob Antimicrob Resist. 2024. PMID: 38552875 Free article. No abstract available.

6

Alternative iron-depleted media for cefiderocol susceptibility testing.

Eales BM, Smith JE, Pouya N, Teran NS, Miller WR, Tam VH. Eales BM, et al. Among authors: tam vh. Int J Antimicrob Agents. 2024 May 7:107193. doi: 10.1016/j.ijantimicag.2024.107193. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38723696 No abstract available.

7

The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy.

Teran N, Egge SL, Phe K, Baptista RP, Tam VH, Miller WR. Teran N, et al. Among authors: tam vh. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0100923. doi: 10.1128/aac.01009-23. Epub 2023 Dec 8. Antimicrob Agents Chemother. 2024. PMID: 38063509 Free PMC article.

8

Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model.

Hudson CS, Smith JE, Eales BM, Kajiji S, Liu X, Truong LD, Tam VH. Hudson CS, et al. Among authors: tam vh. J Antimicrob Chemother. 2023 Oct 3;78(10):2435-2441. doi: 10.1093/jac/dkad246. J Antimicrob Chemother. 2023. PMID: 37563789

9

Rapid In Vitro Assessment of Antimicrobial Drug Effect Bridging Clinically Relevant Pharmacokinetics: A Comprehensive Methodology.

Nikolaou M, Tam VH. Nikolaou M, et al. Among authors: tam vh. Pharmaceutics. 2023 Jun 7;15(6):1671. doi: 10.3390/pharmaceutics15061671. Pharmaceutics. 2023. PMID: 37376120 Free PMC article.

10

Optimizing Clinical Outcomes Through Rational Dosing Strategies: Roles of Pharmacokinetic/Pharmacodynamic Modeling Tools.

Chua HC, Tam VH. Chua HC, et al. Among authors: tam vh. Open Forum Infect Dis. 2022 Dec 16;9(12):ofac626. doi: 10.1093/ofid/ofac626. eCollection 2022 Dec. Open Forum Infect Dis. 2022. PMID: 36540388 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

201 results

Search Page